Report Categories

Peptide-drug conjugates (PDCs) consist of a cytotoxic payload, a homing peptide, and a linker between the peptide and the cytotoxic payload. Following antibody-drug conjugates, they are the next generation of targeted therapeutics with enhanced cell permeability and better drug selectivity. They offer excellent opportunities for targeting cancer, metabolic diseases, and more. Although the potential is huge, development challenges such as poor stability, poor targeting, and potential payload toxicity may slow down preclinical and clinical development processes. CDMO services refer to pharmaceutical companies and biotechnology companies outsourcing the research and development and production of their drugs or biologics to professional CDMO companies. These CDMO companies provide a range of services, including but not limited to drug synthesis, chemical and biological analysis, formulation development, clinical production, and commercial production. The core of CDMO services lies in its customization and specialization capabilities, which can meet the specific needs of different customers at different stages.

USD3480.00

Add To Cart

Peptide-drug conjugates (PDCs) consist of a cytotoxic payload, a homing peptide, and a linker between the peptide and the cytotoxic payload. Following antibody-drug conjugates, they are the next generation of targeted therapeutics with enhanced cell permeability and better drug selectivity. They offer excellent opportunities for targeting cancer, metabolic diseases, and more. Although the potential is huge, development challenges such as poor stability, poor targeting, and potential payload toxicity may slow down preclinical and clinical development processes. CDMO services refer to pharmaceutical companies and biotechnology companies outsourcing the research and development and production of their drugs or biologics to professional CDMO companies. These CDMO companies provide a range of services, including but not limited to drug synthesis, chemical and biological analysis, formulation development, clinical production, and commercial production. The core of CDMO services lies in its customization and specialization capabilities, which can meet the specific needs of different customers at different stages.

USD4480.00

Add To Cart